Successful Cortrophin Gel Launch Could Drive Growth At ANI For Years To Come
Firm Expects To Scale Up Rare Diseases Unit And Generics Going Forward
The launch of ANI Pharmaceutical’s Cortrophin gel has reignited interest in the ACTH drug category, and appears set to drive growth at the company for the foreseeable future.
